| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. | Chief Medical Officer | Stock option (right to buy) | 165,000 | 03 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | 03 Mar 2025 | 1 | $0 | 4 | Chief Medical Officer | 05 Mar 2025, 16:29 |
| CATX | Perspective Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Chief Medical Officer | 24 Jun 2024, 16:07 |
| CATX | Perspective Therapeutics, Inc. | 24 Jan 2024 | 1 | +$139,888 | 4 | Chief Medical Officer | 26 Jan 2024, 17:40 |
| CATX | Perspective Therapeutics, Inc. | 15 Dec 2023 | 3 | +$188,737 | 4 | Chief Medical Officer | 19 Dec 2023, 19:09 |
| CATX | Perspective Therapeutics, Inc. | 12 Dec 2023 | 1 | $0 | 4 | Chief Medical Officer | 14 Dec 2023, 18:44 |
| CATX | Isoray, Inc. | 03 Feb 2023 | 0 | $0 | 3 | Chief Medical Officer | 13 Feb 2023, 15:32 |